Cite

HARVARD Citation

    Weinblatt, M. et al. (2018). A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Arthritis & rheumatology. 70 (1), pp. 49-59. [Online]. 
  
Back to record